← back to search

Wolfgang Högler

University of Birmingham · GB
Area of research
Oncology · Orthopedics and Sports Medicine
Research interest
Research interests include Medicine, Pediatrics, Rickets, Hypophosphatemia, Physical therapy, and Context (archaeology).
h-index
citations
1,206
works
21
NIH funding
primary concept
email

Recent publications

Influence of mode of delivery on neonatal QTc
Journal of Perinatology 2026cited by 0position: middledoi
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Nature Reviews Nephrology 2025cited by 45position: middledoi
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period
JBMR Plus 2024cited by 20position: middledoi
High Parathyroid Hormone Rather than Low Vitamin D Is Associated with Reduced Event-Free Survival in Childhood Cancer
Cancer Epidemiology Biomarkers & Prevention 2024cited by 2position: middledoi
Kenntnisse und tatsächliche Umsetzung der Empfehlungen zur Prävention des plötzlichen Säuglingstods innerhalb des ersten Lebensjahres – eine Analyse longitudinaler Daten der KUNO Kids Gesundheitsstudie
Somnologie - Schlafforschung und Schlafmedizin 2024cited by 0position: middledoi
Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document
The Journal of Clinical Endocrinology & Metabolism 2023cited by 24position: middledoi
Implementation of safe infant sleep recommendations during night-time sleep in the first year of life in a German birth cohort
Scientific Reports 2023cited by 3position: middledoi
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia
The Journal of Clinical Endocrinology & Metabolism 2022cited by 75position: middledoi
Utilisation of supplementary prenatal screening and diagnostics in Germany: cross-sectional study using data from the KUNO Kids Health Study
BMC Pregnancy and Childbirth 2022cited by 1position: middledoi
Prevalences of cardiometabolic risk and lifestyle factors in young parents: evidence from a German birth cohort study
BMC Cardiovascular Disorders 2022cited by 1position: middledoi
Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia
The Journal of Clinical Endocrinology & Metabolism 2021cited by 88position: middledoi
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
Calcified Tissue International 2021cited by 47position: middledoi
Breastfeeding behavior is not associated with health literacy: evidence from the German KUNO-Kids birth cohort study
Archives of Gynecology and Obstetrics 2021cited by 29position: middledoi
Determinants of maternal health four weeks after delivery: cross-sectional findings from the KUNO-kids health study
BMC Public Health 2021cited by 11position: middledoi
High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench
Journal of Bone and Mineral Research 2020cited by 14position: middledoi
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
The Lancet 2019cited by 364position: middledoi
A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents
The Journal of Clinical Endocrinology & Metabolism 2019cited by 112position: middledoi
Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study
The Journal of Clinical Endocrinology & Metabolism 2019cited by 75position: middledoi
Nutritional rickets in immigrant and refugee children
Public health reviews 2016cited by 75position: lastdoi
Bone Health in Children and Adolescents With Chronic Diseases That May Affect the Skeleton: The 2013 ISCD Pediatric Official Positions
Journal of Clinical Densitometry 2014cited by 130position: middledoi
Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis
Human Molecular Genetics 2012cited by 90position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Craig F. Munns · Children's Medical Research Institute7 papers (2016–2024)Leanne M. Ward · University of Birmingham7 papers (2014–2024)Michael P. Whyte · Missouri Bone and Joint Center6 papers (2012–2024)Erik A. Imel · Indiana University School of Medicine5 papers (2019–2024)Anthony A. Portale · University of California, San Francisco5 papers (2019–2024)Raja Padidela · University of Manchester5 papers (2019–2024) · 5 papers (2019–2024)Francis H. Glorieux · Indiana University – Purdue University Indianapolis4 papers (2019–2024) · 4 papers (2019–2024) · 4 papers (2019–2024)Alison Skrinar · Indiana University – Purdue University Indianapolis4 papers (2019–2022)Ola Nilsson · Karolinska University Hospital4 papers (2019–2024)Angel Chen · University of California, Santa Barbara4 papers (2021–2024)Jill H. Simmons · Children's Healthcare of Atlanta3 papers (2019–2024)Andrew Biggin · University of Liverpool3 papers (2019–2024)Farzana Perwad · University of California, San Francisco3 papers (2019–2024)Etienne Sochett · Hospital for Sick Children3 papers (2019–2024) · 3 papers (2019–2024)Pisit Pitukcheewanont · Lumos Pharma (United States)3 papers (2019–2024) · 2 papers (2021–2022)